| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $516,774 | 7 | 100 |
Sells | $0 | 0 | 0 |
| Higuchi John W. | director | 5 | $415,524 | 0 | $0 | $415,524 |
| Patel Mahesh V. | Chief Executive Officer | 2 | $101,250 | 0 | $0 | $101,250 |
Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic conditions. A core aspect of the company's research and development involves formulating oral delivery methods for pharmaceutical compounds that typically suffer from low bioavailability. Its foremost investigational therapy is TLANDO, an oral solution for testosterone replacement. The company's development pipeline also encompasses several other …
Over the last 12 months, insiders at Lipocine Inc. have bought $516,774 and sold $0 worth of Lipocine Inc. stock.
On average, over the past 5 years, insiders at Lipocine Inc. have bought $261,129 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Higuchi John W. (director) — $415,524. Patel Mahesh V. (Chief Executive Officer) — $101,250.
The last purchase of 15,970 shares for transaction amount of $35,613 was made by Higuchi John W. (director) on 2026‑09‑30.
| 2026-09-30 | Higuchi John W. | director | 15,970 0.1964% | $2.23 | $35,613 | -26.82% | ||
| 2026-09-29 | Higuchi John W. | director | 9,037 0.1091% | $2.15 | $19,430 | -25.00% | ||
| 2026-09-28 | Higuchi John W. | director | 12,561 0.158% | $2.16 | $27,132 | -22.49% | ||
| 2026-04-07 | Higuchi John W. | director | 40,000 0.7456% | $2.03 | $81,200 | +10.50% | ||
| 2026-04-06 | Higuchi John W. | director | 123,000 2.3869% | $2.05 | $252,150 | +13.92% | ||
| 2026-04-06 | Patel Mahesh V. | Chief Executive Officer | 25,000 0.4804% | $2.03 | $50,750 | +13.92% | ||
| 2026-04-02 | Patel Mahesh V. | Chief Executive Officer | 25,000 0.1003% | $2.02 | $50,500 | +7.80% | ||
| 2023-05-25 | Patel Mahesh V. | CEO and President | 8,706 0.1614% | $5.03 | $43,791 | -23.22% | ||
| 2023-03-24 | Patel Mahesh V. | CEO and President | 150,000 0.0107% | $0.32 | $48,000 | -21.29% | ||
| 2023-03-20 | Ono Richard Dana | director | 4,000 0.0003% | $0.34 | $1,360 | -28.03% | ||
| 2023-03-17 | Patel Mahesh V. | CEO and President | 50,000 0.0032% | $0.33 | $16,500 | -32.85% | ||
| 2022-11-22 | Papapetropoulos Spyros | director | 21,739 0.0015% | $0.47 | $10,217 | -37.21% | ||
| 2022-11-14 | Patel Mahesh V. | CEO and President | 75,000 0.0051% | $0.39 | $29,250 | -23.07% | ||
| 2022-09-27 | Patel Mahesh V. | CEO and President | 100,000 0.0069% | $0.41 | $41,000 | -19.07% | ||
| 2022-05-17 | Fogarty Krista | Principal Accounting Officer | 12,500 0.0008% | $0.86 | $10,750 | -48.85% | ||
| 2022-05-16 | Patel Mahesh V. | CEO and President | 50,000 0.0032% | $0.77 | $38,495 | -39.61% | ||
| 2021-11-18 | Patel Mahesh V. | CEO and President | 25,000 0.0017% | $1.09 | $27,250 | -21.10% | ||
| 2020-12-31 | Sale | Higuchi John W. | director | 6,700 0.0005% | $1.35 | $9,054 | -0.74% | |
| 2020-12-16 | Sale | Patel Mahesh V. | Chief Executive Officer | 15,000 0.0013% | $1.35 | $20,250 | -1.45% | |
| 2020-12-16 | Sale | BROWN MORGAN R | EVP and CFO | 8,437 0.0007% | $1.35 | $11,390 | -1.45% |
| Higuchi John W. | director | 241365 2.9277% | $352,392.90 | 7 | 1 | +337.5% |
| Patel Mahesh V. | Chief Executive Officer | 160679 1.949% | $234,591.34 | 18 | 4 | +40.01% |
| Papapetropoulos Spyros | director | 21739 0.2637% | $31,738.94 | 1 | 0 | <0.0001% |
| Ono Richard Dana | director | 14125 0.1713% | $20,622.50 | 2 | 1 | +6.64% |
| Fogarty Krista | Principal Accounting Officer | 12500 0.1516% | $18,250.00 | 1 | 0 | <0.0001% |
| HILL STEPHEN A | director | 5250 0.0637% | $7,665.00 | 1 | 1 | +48.99% |
$18,815,063 | 62 | -6.45% | $13.7M | |
$1,993,425 | 46 | -21.91% | $13.95M | |
$95,567,744 | 39 | -17.01% | $10.94M | |
$30,257,839 | 29 | -15.72% | $12M | |
$76,600 | 22 | -38.58% | $10.49M |
| Increased Positions | 15 | +71.43% | 1M | +217.17% |
| Decreased Positions | 6 | -28.57% | 48,834 | -9.23% |
| New Positions | 8 | New | 1M | New |
| Sold Out Positions | 4 | Sold Out | 24,832 | Sold Out |
| Total Postitions | 30 | +42.86% | 2M | +207.95% |
| Vanguard Group Inc | $1,775.00 | 3.7% | 221,867 | -3,009 | -1.34% | 2025-09-30 |
| Blackrock, Inc. | $714.00 | 1.49% | 89,272 | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $489.00 | 1.02% | 61,076 | 0 | 0% | 2025-09-30 |
| Susquehanna International Group, Llp | $374.00 | 0.78% | 46,761 | +742 | +1.61% | 2025-09-30 |
| Renaissance Technologies Llc | $289.00 | 0.6% | 36,097 | +1,300 | +3.74% | 2025-09-30 |
| State Street Corp | $149.00 | 0.31% | 18,626 | 0 | 0% | 2025-09-30 |
| Citadel Advisors Llc | $114.00 | 0.24% | 14,247 | +14,247 | New | 2025-09-30 |
| Northern Trust Corp | $105.00 | 0.22% | 13,160 | 0 | 0% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $97.00 | 0.2% | 12,140 | -11,722 | -49.12% | 2025-09-30 |
| Barclays Plc | $75.00 | 0.16% | 9,412 | 0 | 0% | 2025-09-30 |